RLAY FY 2019 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$84M

Net Income

-$67M

EPS (Diluted)

$-15.53

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$74M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$393M

Total Liabilities

$574M

Stockholders' Equity

-$180M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$2M	-32.1%
Operating Income	-$84M	-$50M	-68.5%
Net Income	-$67M	-$49M	-36.3%